UK markets closed

LAVA Therapeutics N.V. (LVTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8400-0.1900 (-6.27%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
44,231
100,333
90,869
15,818
Other short-term investments
51,340
32,535
42,334
0
Total cash
95,571
132,868
133,203
15,818
Net receivables
1,459
3,254
363
1,140
Other current assets
1,627
4,411
2,568
116.8454
Total current assets
98,897
140,533
136,505
18,222
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,229
3,187
2,576
1,833
Accumulated depreciation
-1,735
-1,104
-630
-338
Net property, plant and equipment
2,494
2,083
1,946
1,495
Other long-term assets
319
809
796
769
Total non-current assets
2,813
2,892
2,742
2,264
Total assets
101,710
143,425
139,247
20,486
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
5,282
4,640
-
-
Accounts payable
4,446
3,965
2,553
934
Accrued liabilities
4,291
7,788
1,569
1,266
Deferred revenues
-
0
1,527
4,521
Other current liabilities
482
5,137
5,338
107
Total current liabilities
14,941
21,954
11,248
7,335
Non-current liabilities
Long-term debt
-
-
4,284
3,604
Deferred revenues
35,000
35,000
0
1,655
Other long-term liabilities
-
-
5,028
-
Total non-current liabilities
35,591
35,431
9,632
5,530
Total liabilities
50,532
57,385
20,880
12,865
Stockholders' equity
Common stock
3,715
3,715
3,653
0
Retained earnings
-148,067
-108,069
-76,162
-33,386
Accumulated other comprehensive income
1,106
-4,030
-1,394
-81
Total stockholders' equity
51,178
86,040
118,367
7,621
Total liabilities and stockholders' equity
101,710
143,425
139,247
20,486